Sponsor Pipeline

FoRx Therapeutics AG Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
Active Trials by Phase
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07356453 A Study of PARG Inhibitor FORX-428 in Patients With Advanced Solid Tumors. Advanced Solid Tumors Recruiting
Get alerts when FoRx Therapeutics AG's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free